Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase. See why I rate HIMS stock a ...

Hims & Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public ...

Celebrating 30 Years of Innovation Excellence with Advanced OEM Solutions for Healthcare Successful Showcase: ADLINK's latest ...

Suki is establishing itself as a darling of some of the largest health care companies in the country. On March 3, Rush—the ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

We recently compiled a list of the 10 Best Skincare Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Hims & Hers Health has called time on Apostrophe, its personalised acne treatments business. The San Francisco-based ...

These calculated actions support the firm’s goal of adding new verticals to its current infrastructure at a little expense to generate enormous long-term value. Overall HIMS ranks 6th on our ...

In an increasingly competitive telehealth weight loss market, thoughtful and transparent branding is critical.